Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects

Molecular Therapy. Methods & Clinical Development
Yaron Ilan

Abstract

Chronic administration of drugs leads to the activation of compensatory mechanisms that may inhibit some of their activity and induce unwanted toxicity. These mechanisms are an obstacle for maintaining a sustainable effect for many chronic medications. Pathways that adapt to the burden induced by chronic drugs, whether or not related to the underlying disease, can lead to a partial or complete loss of effect. Variability characterizes many biological systems and manifests itself as large intra- and inter-individual differences in the response to drugs. Circadian rhythm-based chronotherapy is further associated with variability in responses noted among patients. This paper reviews current knowledge regarding the loss of effect of chronic medications and the range of variabilities that have been described in responses and loss of responses. Establishment of a personalized platform for overcoming these prohibitive mechanisms is presented as a model for ensuring long-term sustained medication effects. This novel platform implements personalized variability signatures and individualized circadian rhythms for preventing and opposing the prohibitive effect of the compensatory mechanisms induced by chronic drug administration.

References

Sep 13, 2002·Journal of the American College of Cardiology·John E DeanfieldUNKNOWN CAPE II Trial Investigators
Mar 21, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Dariusz Koziorowski, Andrzej Friedman
Apr 4, 2007·The American Journal of Medicine·Barry J Materson
Jun 28, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Grzegorz GarbaczWerner Weitschies
Jul 11, 2008·Clinical Pharmacology and Therapeutics·S U YasudaS-M Huang
Aug 1, 2008·Current Clinical Pharmacology·Ehab S El DesokyUlrich Klotz
Jun 26, 2009·Journal of Pharmacokinetics and Pharmacodynamics·Jun Li, Fahima Nekka
Jul 28, 2010·Annals of Neurology·Joep KillesteinChris H Polman
Nov 26, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Vivencio Barrios, Carlos Escobar
Mar 17, 2011·The American Journal of Gastroenterology·Vincent BillioudLaurent Peyrin-Biroulet
May 28, 2011·Diabetes Care·Eli A Friedman, Mary Ann Banerji
Jun 28, 2011·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Amrita X Sarkar, Eric A Sobie
Jul 26, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A BeckerE F Smit
Jun 5, 2012·Expert Opinion on Drug Discovery·Stuart N FarrowTimothy M Willson
Jan 19, 2013·International Journal of Clinical Pharmacy·Gagandeep KaurBandana Saini
Jun 25, 2013·Autoimmunity Reviews·Shomron Ben-HorinYehuda Chowers
Aug 21, 2013·Basic & Clinical Pharmacology & Toxicology·Annalisa BrunoPaola Patrignani
Nov 30, 2013·Frontiers in Neuroendocrinology·Matthew Bailey, Rae Silver
Apr 26, 2014·World Journal of Gastroenterology : WJG·Gianluigi MazzoccoliAda Piepoli
Nov 11, 2014·Drug Development Research·Martina Biggioggero, Ennio Giulio Favalli
Jan 13, 2015·British Journal of Pharmacology·E V Gurevich, V V Gurevich
Mar 25, 2015·Nature Reviews. Rheumatology·Frank ButtgereitChristian Cajochen
Apr 22, 2015·International Journal of Endocrinology·M A UlhôaC R C Moreno
May 11, 2015·FEBS Letters·Thomas Wallach, Achim Kramer
Jun 27, 2015·Current Psychiatry Reports·Sara Dallaspezia, Francesco Benedetti
Aug 13, 2015·Molecular Cancer Therapeutics·Brion W Murray, Nichol Miller
Aug 21, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaodong WangChristopher J Sweeney
Oct 3, 2015·Seminars in Cell & Developmental Biology·Maicol Mancini, Yosef Yarden
Oct 3, 2015·Reviews of Physiology, Biochemistry and Pharmacology·Jonathan P Mochel, Meindert Danhof
Dec 15, 2015·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ramón C HermidaFrancesco Portaluppi
Dec 25, 2015·NeuroImage. Clinical·Alison C SimioniLesley K Fellows
Feb 26, 2016·Methods in Molecular Biology·José Rueff, António Sebastião Rodrigues
Mar 15, 2016·Pain Management·Ian Gilron

❮ Previous
Next ❯

Citations

Jan 23, 2021·International Journal of Environmental Research and Public Health·Yaron Ilan
Aug 5, 2021·American Journal of Physiology. Gastrointestinal and Liver Physiology·Yuval IshayYaron Ilan

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03843697
NCT03747705

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.